Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
| Actual shortage: | 46 (10%) | |
| Anticipated shortage: | 15 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| OLMESARTAN | 20MG | TABLET | Resolved | 2023-07-31 | 2024-01-17 | 200465 |
| OLMESARTAN | 20MG | TABLET | Actual shortage | 2024-03-11 | 2024-03-11 | 221869 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-07-31 | 2023-09-25 | 200456 |
| OLMESARTAN | 40MG | TABLET | Resolved | 2023-10-23 | 2024-02-12 | 207885 |
| OLMESARTAN | 40MG | TABLET | Actual shortage | 2024-03-11 | 2024-03-11 | 221872 |
| TADALAFIL | 5MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200477 |
| TADALAFIL | 20MG | TABLET | Resolved | 2023-07-31 | 2023-12-26 | 200474 |
| LETROZOLE | 2.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223376 |
| IMATINIB | 100MG | TABLET | Anticipated shortage | 2024-04-19 | 2024-04-19 | 225711 |
| IMATINIB | 400MG | TABLET | Anticipated shortage | 2024-04-19 | 2024-04-19 | 225714 |
| OLMESARTAN/HCTZ | 20MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223386 |
| OLMESARTAN/HCTZ | 40MG 25MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223370 |
| OLMESARTAN/HCTZ | 40MG 12.5MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223383 |
| LACOSAMIDE | 100MG | TABLET | Resolved | 2023-07-31 | 2023-11-06 | 200437 |
| LACOSAMIDE | 150MG | TABLET | Resolved | 2023-11-22 | 2024-01-30 | 211034 |
| CAPECITABINE | 150MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223358 |
| CAPECITABINE | 500MG | TABLET | Anticipated shortage | 2024-03-26 | 2024-05-08 | 223361 |
| RIZATRIPTAN | 10MG | TABLET | Resolved | 2023-07-31 | 2023-08-28 | 200440 |
| VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-10-23 | 2023-12-01 | 207872 |
| VALACYCLOVIR | 1000MG | TABLET | Actual shortage | 2024-03-25 | 2024-03-26 | 223251 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |